FCGSX
Price
$19.73
Change
+$0.01 (+0.05%)
Updated
Apr 17 closing price
Net Assets
15.76B
VIGRX
Price
$181.21
Change
+$0.19 (+0.10%)
Updated
Apr 17 closing price
Net Assets
260.76B
Ad is loading...

FCGSX vs VIGRX

Header iconFCGSX vs VIGRX Comparison
Open Charts FCGSX vs VIGRXBanner chart's image
Fidelity Series Growth
Price$19.73
Change+$0.01 (+0.05%)
VolumeN/A
Net Assets15.76B
Vanguard Growth Index Investor
Price$181.21
Change+$0.19 (+0.10%)
VolumeN/A
Net Assets260.76B
FCGSX vs VIGRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FCGSX vs. VIGRX commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FCGSX is a Hold and VIGRX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 261B vs. FCGSX (15.8B). FCGSX pays higher dividends than VIGRX: FCGSX (0.51) vs VIGRX (0.39). FCGSX was incepted earlier than VIGRX: FCGSX (11 years) vs VIGRX (32 years). VIGRX (0.17) is less costly to investors than FCGSX (0.00). FCGSX is a more actively managed with annual turnover of: 27.00 vs. VIGRX (5.00). FCGSX has a lower initial minimum investment than VIGRX: FCGSX (0) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 6.01 vs. FCGSX (-7.75). VIGRX return over 5 years is better than : 99.21 vs. FCGSX (11.57).
FCGSXVIGRXFCGSX / VIGRX
Total Expense Ratio0.000.17-
Annual Report Gross Expense Ratio0.000.17-
Fund Existence11 years32 years-
Gain YTD-17.730-14.326124%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets15.8B261B6%
Annual Yield % from dividends0.510.39133%
Returns for 1 year-7.756.01-129%
Returns for 3 years17.3130.3357%
Returns for 5 years11.5799.2112%
Returns for 10 years58.55223.8426%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RCKT6.330.18
+2.93%
Rocket Pharmaceuticals
OVV33.820.72
+2.18%
Ovintiv
USAC25.220.29
+1.16%
USA Compression Partners LP
UNB31.340.35
+1.13%
Union Bankshares
VVOS2.100.02
+0.96%
Vivos Therapeutics